相关实验视频

Updated: Sep 11, 2025

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

在多发性硬化症中的aHSCT

Guillermo José Ruiz-Argüelles^1,2

¹Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, Mexico.

British journal of haematology

|August 19, 2025

概括

自主造血干细胞移植 (aHSCT) 显示出对多发性硬化症 (MS) 治疗在所有疾病形式中的承诺. 这种强大的疗法提供了一个潜在的更安全,更实惠的替代方案,新的MS药物.

科学领域:

血液学血液学血液学
神经学神经学
免疫学免疫学免疫学

背景情况:

多发性硬化症 (MS) 是一种慢性自身免疫性疾病,影响中枢神经系统.
目前用于MS的治疗方法在有效性和安全性方面存在局限性.
自主造血干细胞移植 (aHSCT) 是一个新兴的治疗选择.

研究的目的:

分析英国在多发性硬化症中使用HSCT的经验.
评估aHSCT在不同多发性硬化症亚型中的有效性和结果.
将aHSCT与MS的现有和新型治疗方法进行比较.

主要方法:

对364名患有多发性硬化症 (MS) 的患者进行回顾性分析,这些患者接受了HSCT.
来自英国血液和骨髓移植和细胞治疗学会 (BSBMTCT) 的数据.
对复发性复发性和其他MS形式的治疗反应的评估.

主要成果:

在所有类型的多发性硬化症中观察到对aHSCT的积极反应.
在复发性复发性MS形式中,应答率优于复发性复发性MS.
aHSCT表现出令人鼓舞的结果,支持其在MS管理中的作用.

结论:

自主造血干细胞移植 (aHSCT) 是对多发性硬化症 (MS) 的强有力的治疗方法.
与许多新型MS药物相比,aHSCT似乎更有效,更安全,更实惠.
患者和家庭倡导强调HSCT作为一个重要的治疗进步.

关键词:

一个HSCTCT.多发性硬化症多发性硬化症治疗治疗治疗治疗治疗治疗

更多相关视频

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...